Jul 2026· Journal of Immunology· Vol 215· 0 citations
TL;DR
Preliminary results indicate that CCL11-KO mice are more susceptible to infection compared to controls, highlighting a complex role for CCL11 in balancing antiviral defense and neuro inflammation, and investigating CCL11 as a potential mediator linking peripheral respiratory infection to persistent neuroinflammation.
Abstract
Growing evidence suggests that peripheral infections contribute to neurodegenerative disease progression and cognitive impairment, yet the underlying neuro-immune mechanisms remain poorly understood.
Here, we used a mouse model of Influenza A virus (H1N1) respiratory infection to investigate immune responses in the central nervous system (CNS).
At day 6 post-infection, we observed significant increases in microglia, perivascular macrophages, monocytes, NK cells, and neutrophils, indicating infection-driven immune activation within the CNS. Strikingly, eosinophils persisted in both brain/leptomeninges and dura mater up to 7 weeks post-infection. No viral RNA was detected in the brain at any time point, whereas lung tissue harbored high viral loads, suggesting peripheral infection as the driver of neuroinflammation. Cytokine and chemokine profiling revealed persistent elevation of CCL11 in serum at both day 6 and week 7. CCL11 has been implicated in other peripheral infection related neuroinflammation, potentially contributing to myelin loss and impaired neurogenesis, although mechanisms remain unknown. To address the role of CCL11 in CNS inflammation and dysfunction in this context, we have begun characterizing CCL11 knockout (KO) mice following influenza infection. Preliminary results indicate that CCL11-KO mice are more susceptible to infection compared to controls, highlighting a complex role for CCL11 in balancing antiviral defense and neuroinflammation. Furthermore, scRNA-seq analysis of healthy mice revealed high CCL11 expression in dural sinus smooth muscle cells, leptomeningeal fibroblasts and brain pericytes suggesting that brain border cells may contribute to local regulation of immune responses after infection.
Moving forward, our goal is to investigate CCL11 as a potential mediator linking peripheral respiratory infection to persistent neuroinflammation, providing insight into mechanisms by which infections may contribute to long-term brain dysfunction.
Emerging pathogen consortia, HHMI
Neuroimmunology (NEUR)
HSE is discussed as a dynamic immunopathological disorder in which protective innate immunity can transition into pathogenic neuroinflammation and host-directed therapeutic strategies should shift from uniform immune modulation toward stage-specific immune recalibration on the basis of viral control, antiviral competen...
Sheng Yang, Yang-Kun Shen, Chunfu Zheng· Current Opinion in Virology· 1 citation
It is demonstrated that CSF contains cellular and transcriptional profiles that differ from those observed in peripheral blood and vary according to the anatomical sampling site, demonstrating the potential of high-dimensional profiling to resolve compartmentalized neuroimmune responses during CNS infection.
Antiretroviral therapy (ART) effectively suppresses systemic HIV replication but does not eradicate viral reservoirs in the brain, where their identity and contribution to neurological injury remain poorly defined. Using bulk, single-cell, and single-nucleus transcriptomics of postmortem human brain tissue, we identify...
C. S. Shabangu, Hong-Jie Chen, A. Manickam et al.· bioRxiv· 0 citations
The microglia-containing assembloid model replicates in vivo neurodevelopmental interactions, allowing high-resolution analysis of homeostatic and HIV-induced responses across different brain cell types and uncovered previously unknown crosstalk.
Sheetal Sreeram, Ya Chen, L. Bury et al.· bioRxiv· 0 citations
Findings indicate that brain organoids and NPC-based in vitro platforms provide a novel approach for studying brain tuberculosis, and that decreased NPC function may contribute to brain tuberculosis-induced cognitive disease.
Recent advances regarding the pivotal role of ILC2s in neural-immune crosstalk are summarized, the pathophysiological consequences of neuro–ILC2 axis dysregulation are discussed, and emerging therapeutic strategies targeting these cellular interfaces for the treatment of inflammatory, allergic, and neurological disease...
Qiang Liu, Jie Zhou· Immunity & Inflammation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.